Intraocular melanoma

Active Research Protocols

  1. 13-C-0093 – Phase II Study in Patients with Metastatic Ocular Melanoma Using a Non-Myeloablative Lymphocyte Depleting Regimen of Chemotherapy Followed by Infusion of Autologous Tumor-Infiltrating Lymphocytes with or without High Dose Aldesleukin
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014